BF Biosciences Limited is a joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina and Pakistan’s first biopharmaceutical production facility, designed to USFDA standards.
In 2002, Ferozsons and Bagó entered into commercial partnership to launch the Bagó range of quality branded generics in the field of oncology and hepatology in Pakistan. Within the first two years, together we achieved a leadership position, becoming one of the top 3 companies in both Oncology and hepatology segments.
n December 2004, Bagó and Ferozsons signed agreed in principle to enter into a joint-venture in Pakistan. The agreement to form BF Biosciences Limited, Pakistan’s first biotech formulation company was signed in 2006. The plant, which has been built on a 27 acre site in Lahore, Pakistan , was completed in 2009 and manufactures biological medicines to treat Cancer and Hepatitis C for the local and export markets.The joint-venture has put Pakistan on the map of countries with biotech manufacturing capacity. As the first USFDA compliant pharmaceutical facility in the country, we have also helped Pakistan join the select group of companies that are exporting biotech pharmaceuticals. Exports have already commenced to Asian Markets.
The BF Biosciences manufacturing Facility is a Pioneer in the Biotechnology sector in Pakistan:
• Our manufacturing facility was designed and installed by leading European Pharmaceutical Designers “Telstar Projects” to comply fully with EMEA and USFDA standards. Telstar has previously completed several FDA approved facilities in Europe and the United States.
•The BF project represents the first USFDA compliant pharmaceutical facility of any category in the country.
•The manufacturing equipment is designed to ensure complete segregation between different products under formulation, whether biologicals, vaccines or other parenterals. All contact parts are completely changeable when shifting from one product to another. The facility is also designed to ensure biological/bio-hazard containment.
• Special Gowning for clean areas and segregated gowning for support areas. Personnel involved in the formulation area go through three change rooms and undertake three different changes of clothing.
• Special Hatches developed for the clean rooms which not only have UV lights but also H14 ventilated systems to ensure proper cleanliness as per FDA guidelines